HO prevention and the combined therapeutic protocol—do we really need it?
暂无分享,去创建一个
[1] E. Pakos,et al. Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol , 2006, International Orthopaedics.
[2] A. Giurea,et al. Ossifikationsprophylaxe nach Hüft-TEP mit Indomethacin: Analyse von Risikofaktoren , 2005 .
[3] A. Giurea,et al. [Prevention of heterotopic ossification after THA with indomethacin: analysis of risk factors]. , 2005, Zeitschrift fur Orthopadie und ihre Grenzgebiete.
[4] M. Handel,et al. Risikofaktoren für heterotope Ossifikationen in der primären Hüftgelenkstotalendoprothetik , 2004 .
[5] J. Brettschneider,et al. [Risk factors associated with heterotopic ossifications in primary total hip arthroplasty]. , 2004, Zeitschrift fur Orthopadie und ihre Grenzgebiete.
[6] D. D’Lima,et al. Indomethacin versus radiation therapy for heterotopic ossification after hip arthroplasty. , 2001, Orthopedics.
[7] W. Bruce,et al. Prevention of Heterotopic Bone Formation in High Risk Patients Post-Total Hip Arthroplasty , 2000, Journal of orthopaedic surgery.
[8] B. Moed,et al. Low-dose irradiation and indomethacin prevent heterotopic ossification after acetabular fracture surgery. , 1994, The Journal of bone and joint surgery. British volume.